05.07.10
Results of a human clinical study show that Chromax chromium picolinate from Nutrition 21, Inc. improved memory function in elderly adults with early memory decline.
The double-blind, placebo-controlled clinical study was conducted by researchers at the University of Cincinnati College of Medicine and published in the journal Nutritional Neuroscience.
The study enrolled 26 older adults (12 men, 14 women) with indications of early memory decline, representing increased risk of neurodegeneration and Alzheimer's disease. Study subjects were randomly assigned in a double-blind manner to receive daily chromium picolinate (1000 mcg chromium) or placebo capsules for 12 weeks. Results of the memory tests showed that the chromium-treated subjects made significantly fewer errors in memory. Thirteen subjects (9 chromium-treated and 4 placebo-treated) also completed pre- and post-intervention fMRI brain scans during performance of certain memory tasks. Chromium-treated subjects showed increased brain activation at 12 weeks relative to pre-treatment as compared with unchanged activation for the placebo-treated subjects. For further information: www.nutrition21.com
The double-blind, placebo-controlled clinical study was conducted by researchers at the University of Cincinnati College of Medicine and published in the journal Nutritional Neuroscience.
The study enrolled 26 older adults (12 men, 14 women) with indications of early memory decline, representing increased risk of neurodegeneration and Alzheimer's disease. Study subjects were randomly assigned in a double-blind manner to receive daily chromium picolinate (1000 mcg chromium) or placebo capsules for 12 weeks. Results of the memory tests showed that the chromium-treated subjects made significantly fewer errors in memory. Thirteen subjects (9 chromium-treated and 4 placebo-treated) also completed pre- and post-intervention fMRI brain scans during performance of certain memory tasks. Chromium-treated subjects showed increased brain activation at 12 weeks relative to pre-treatment as compared with unchanged activation for the placebo-treated subjects. For further information: www.nutrition21.com